www.wuxiapptec.com Open in urlscan Pro
163.181.56.213  Public Scan

Form analysis
1 forms found in the DOM

#

<form action="#" class="search" data-v-20411a38=""><label for="search1" data-v-20411a38=""><img
      src="data:image/svg+xml;base64,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"
      data-v-20411a38=""><span data-v-20411a38=""></span></label><input id="search1" type="search" value="" class="search-input" data-v-20411a38=""></form>

Text Content

Contact UsEN简繁
About Us
Services
Platform
News
Careers
Investors


WUXI APPTEC


GLOBAL PLATFORM
ONE VISION




OUR VISION


EVERY DRUG CAN BE MADE
AND EVERY DISEASE CAN BE TREATED

By Building an Open-access Platform with the Most Comprehensive Capabilities and
Technologies in the Global Healthcare Industry


OUR VALUES


INTEGRITY & DEDICATION, WORKING TOGETHER & SHARING SUCCESS;
DOING THE RIGHT THING, DOING IT RIGHT.








OVERVIEW


ENVIRONMENTAL, SOCIAL AND GOVERNANCE (ESG)

View ESG Video



ABOUT US


ENABLING INNOVATION

As a global company with operations across Asia, Europe, and North America, WuXi
AppTec provides a broad portfolio of R&D and manufacturing services that enable
the pharmaceutical and healthcare industry around the world to advance
discoveries and deliver groundbreaking treatments to patients. Through its
unique business models, WuXi AppTec’s integrated, end-to-end services include
chemistry drug CRDMO (Contract Research, Development and Manufacturing
Organization), biology discovery, preclinical testing and clinical research
services, and cell and gene therapies CTDMO (Contract Testing, Development and
Manufacturing Organization), helping customers improve the productivity of
advancing healthcare products through cost-effective and efficient solutions.
WuXi AppTec received AA ESG rating from MSCI in 2022 and its open-access
platform is enabling more than 6,000 customers from over 30 countries to improve
the health of those in need – and to realize the vision that "every drug can be
made and every disease can be treated."

SEE MORE


SERVICES AND SOLUTIONS


AN OPEN ENABLING PLATFORM

Enabling more than 6,000 innovative customers from more than 30 Countries



Small Molecule Drug R&D and Manufacturing

Cell Therapy
and Gene Therapy

Drug R&D and Medical
Device Testing

Clinical
Services



Small Molecule Drug R&D and Manufacturing


COMPANY PLATFORM


ENABLING ANYONE, ANY COMPANY

To Become the Most Comprehensive Capability and Technology Platform in the
Global Pharmaceutical and Healthcare Industry


WUXI CHEMISTRY

Provides CRDMO services
for new drug development from discovery to commercial

SEE MORE


WUXI BIOLOGY

A full spectrum of biology services and solutions
supporting stand-alone and integrated projects

SEE MORE


WUXI TESTING

Seamless drug and medical device testing services
from preclinical testing to clinical trials

SEE MORE


WUXI ADVANCED THERAPIES

Global CTDMO
offering an integrated end-to-end solution to accelerate time to market for cell
and gene therapies

SEE MORE



NEWS


THE LATEST NEWS ABOUT WUXI APPTEC



WuXi AppTec Announced Strong Results of the Second Quarter and First Half of
2023, on Top of an Exceptionally Strong Year in 2022

WuXi AppTec Continued Solid Growth in First-Quarter of 2023 On Top of an
Exceptionally Strong Year of 2022

WuXi AppTec Reports Record Results in 2022

WuXi AppTec Named “Industry Mover” in S&P Global Sustainability Yearbook 2023

WuXi AppTec Named to the 2022 Dow Jones Sustainability World Index

WuXi AppTec Receives 2022 Global Contract Research, Development and
Manufacturing Organization Company of the Year Award from Frost & Sullivan


WUXI APPTEC ANNOUNCED STRONG RESULTS OF THE SECOND QUARTER AND FIRST HALF OF
2023, ON TOP OF AN EXCEPTIONALLY STRONG YEAR IN 2022

(SHANGHAI, July 31, 2023) — WuXi AppTec (stock code: 603259.SH / 2359.HK), a
global company that provides a broad portfolio of R&D and manufacturing services
that enable companies in the pharmaceutical, biotech and medical device
industries to advance discoveries and deliver groundbreaking treatments to
patients, is pleased to announce its financial results for the first half ending
June 30, 2023 (“Reporting Period”).

Read more


WUXI APPTEC CONTINUED SOLID GROWTH IN FIRST-QUARTER OF 2023 ON TOP OF AN
EXCEPTIONALLY STRONG YEAR OF 2022

(SHANGHAI, April 24, 2023) — WuXi AppTec (stock code: 603259.SH / 2359.HK), a
global company that provides a broad portfolio of R&D and manufacturing services
that enable companies in the pharmaceutical, biotech and medical device
industries to advance discoveries and deliver groundbreaking treatments to
patients, is pleased to announce its financial results for the first quarter
ending March 31, 2023 (“Reporting Period”).

Read more


WUXI APPTEC REPORTS RECORD RESULTS IN 2022

SHANGHAI, March 20, 2023 — WuXi AppTec (stock code: 603259.SH / 2359.HK), a
global company that provides a broad portfolio of R&D and manufacturing services
that enable companies in the pharmaceutical, biotech and medical device
industries to advance discoveries and deliver groundbreaking treatments to
patients, is pleased to announce its annual results for the year ending December
31, 2022 (“Reporting Period”).

Read more


WUXI APPTEC NAMED “INDUSTRY MOVER” IN S&P GLOBAL SUSTAINABILITY YEARBOOK 2023

Shanghai, February 15, 2023 – WuXi AppTec, a global company that provides a
broad portfolio of R&D and manufacturing services for the pharmaceutical,
biotech and medical device industries to advance discoveries and deliver
groundbreaking treatments to patients, announced today that it received the
“Industry Mover” award in the S&P Global Sustainability Yearbook 2023. WuXi
AppTec is the only company to be named as “Industry Mover” this year from the
Life Science Tools & Services industry.

Read more


WUXI APPTEC NAMED TO THE 2022 DOW JONES SUSTAINABILITY WORLD INDEX

Shanghai, December 21, 2022 – WuXi AppTec, a leading global provider of R&D and
manufacturing services that enables the global pharmaceutical and healthcare
industry, today announced that it has been included in the 2022 Dow Jones
Sustainability™ World Index (DJSI). This demonstrates the company’s strong
performance and commitment to Environmental, Social and Governance (ESG)
initiatives.

Read more


WUXI APPTEC RECEIVES 2022 GLOBAL CONTRACT RESEARCH, DEVELOPMENT AND
MANUFACTURING ORGANIZATION COMPANY OF THE YEAR AWARD FROM FROST & SULLIVAN

SHANGHAI, November 29, 2022 – WuXi AppTec, a global company that provides a
broad portfolio of R&D and manufacturing services for the pharmaceutical,
biotech and medical device industries to advance discoveries and deliver
groundbreaking treatments to patients, announced that it is a recipient of the
2022 Global Contract Research, Development and Manufacturing Organization
Company of the Year Award from Frost & Sullivan, a global research & consulting
firm that helps customers accelerate growth. This marks the sixth consecutive
year that WuXi AppTec has been recognized by Frost & Sullivan for its leadership
and innovative services.

Read more




CAREERS


WELCOME TO


OUR TEAM

Become Part of Creating a Better Life

Join Us


INVESTORS


THE LATEST FINANCIAL REPORTS, ANNOUNCEMENTS AND RESOURCES



SEE MORE


CONTACT US




WUXI APPTEC MAIN OFFICES

288 Fute Zhong Road
Waigaoqiao Free Trade Zone
Shanghai 200131, China
Tel: +86 (21) 5046-1111
Fax: +86 (21) 5046-1000


ENQUIRIES

Tel: 400-820-0985 (Mainland China)
857-413-2800 (U.S.)
+86 (21) 2066-3734 (Global)
Email: wuxiconcierge@wuxiapptec.com


SOCIAL MEDIA


SEE OUR GLOBAL SITES

© 2020 WuXi AppTec
Terms of Use  |  Privacy Policy  |  Transparency in
Coverage  |  沪ICP备10016157号  |  沪公网安备31011502012242号
© 2020 WuXi AppTec
Terms of Use  |  Privacy Policy  |  Transparency in Coverage  |  沪ICP备10016157号
沪公网安备31011502012242号